SuperworthPalisade Bio market cap PALI
Share price times shares outstanding: what the whole company sells for, since 2011.
- Today, Oct 23, 2026
- $231.8M
- Highest close in our data
- $398.1M
- Apr 2026
Palisade Bio is worth $231.8M at the close on Oct 23, 2026, at $1.33 a share.
That is up 1361% over the last year and up 555% over five years.
Its highest close in our data was $398.1M in Apr 2026.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $231.8M | $222M | $398.1M | −28% |
| 2025 | $320.4M | $945K | $320.4M | +14329% |
| 2024 | $2.2M | $2.2M | $6.6M | −59% |
| 2023 | $5.4M | $2.9M | $15.9M | −32% |
| 2022 | $8M | $1.8M | $21.3M | −55% |
| 2021 | $17.6M | $10.8M | $36.8M | +16% |
| 2020 | $15.2M | $2.5M | $16.3M | +332% |
| 2019 | $3.5M | $2.2M | $10.9M | −40% |
| 2018 | $5.9M | $5.9M | $30.6M | −77% |
| 2017 | $26.1M | $13.3M | $70.9M | −17% |
| 2016 | $31.4M | $20.4M | $94.6M | −67% |
| 2015 | $94.6M | $93.6M | $332.1M | −61% |
| 2014 | $240.3M | $225.4M | $391.4M | +17% |
| 2013 | $205.5M | $72.8M | $207.8M | +175% |
| 2012 | $74.8M | $24.3M | $85M | +59% |
| 2011 | $47M | $46.2M | $74.7M | n/a |
Against its peers
Companies in Biotechnology nearest Palisade Bio's size, closest first, today.
| Company | Market cap |
|---|---|
| PALIPalisade Bio | $231.8M |
| PLXProtalix BioTherapeutics | $205.5M |
| MGTXMeiraGTx | $884.6M |
| VCELVericel | $2.2B |
| Peer median | $884.6M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Palisade Bio
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.